Volume 19, Number 10—October 2013
Research
Plasmodium vivax Malaria during Pregnancy, Bolivia
Table 5
Characteristic | Multiple linear regression, n = 329 |
Logistic regression, n = 329 |
||
---|---|---|---|---|
Adjusted difference in mean birthweight, g (95% CI)† | p value | Adjusted OR for low birthweight (95% CI) | p value | |
Baby | ||||
Mature | 0 | <0.001 | 1 | NS |
Premature | –426 (−626 to −227) | NS | 10.5 (2.8–39.8) | 0.001 |
Boy | 0 | NS | NS | 0.98 |
Girl | –135 (−237 to −34) | 0.009 | NS | 0.98 |
Multiparous mother | 0 | NS | NS | 0.52 |
Primiparous mother | –181 (−287 to −75) | 0.001 | NS | 0.52 |
No anemia at delivery | 0 | 0.08 | NS | 0.69 |
Anemia at delivery | – 92 (−195 to 10) | 0.08 | NS | 0.69 |
Not infected at antenatal visits | 0 | NS | 1 | NS |
Infected with Plasmodium vivax at antenatal visits | – 266 (−453 to −78) | 0.006 | 8.8 (2.4–32.5) | 0.001 |
*OR, odds ratio; NS, not significant. Significant values (<0.05) are indicated in boldface. Multivariate models adjusting for mother’s age, maternal anemia, number of previous pregnancies, and sex and gestational age of the baby. Only significant variables (p<0.10) from the linear regression model are shown. The same variables were used for logistic regression model.
†Baseline mean birthweight was 3,538 g.
Page created: August 14, 2013
Page updated: September 16, 2013
Page reviewed: September 16, 2013
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.